Overview of BCG Vaccine Market Report Helps In Providing Scope and Definitions, Key Findings, Growth Drivers, and Various Dynamics.
Tuberculosis (TB) is a communicable infectious disease caused by the Mycobacterium tuberculosis bacteria. The disease affects the lungs, and it travels through the air from person to person. Tuberculosis is preventable and curable, and the vaccine Bacille Calmette-Guérin (BCG) is offered as part of its care. The vaccine for BCG tuberculosis is produced using a debilitated strain of TB bacteria. While no effective vaccine is currently available for preventing TB disease in adults, the BCG TB vaccine is commonly used to prevent serious types of TB in children. BCG vaccine is expected to be a game changer in the COVID-19 crisis. While the US has registered nearly 1.90,000 cases and more than 4,000 deaths, Italy has 1.05,000 cases and more than 12,000 deaths. More than 12,000 cases of the disease and more than 1,000 deaths recorded in the Netherlands. A combination of abridged mortality and morbidity could make BCG vaccine a game changer in the fight against coronavirus. Tuberculosis and infection with Covid-19 are two very different diseases — TB is caused by a form of bacteria, whereas for example, Covid-19 is caused by virus. But the BCG vaccine can help individuals develop immune responses to things other than TB, causing “off-target effects.”
Gets Sample of Global BCG Vaccine Market Report @ https://www.arcognizance.com/enquiry-sample/1220661
BCG vaccination averts serious types of tuberculosis in children, and alteration in local supplies can cause neonates not to be vaccinated, leading to increased disease and tuberculosis deaths. Currently, WHO is not recommending BCG vaccination for coronavirus protection, due to absence of evidence. This is a key factor hampering the overall growth. However, increasing demand for this vaccine for testing, research and trials purposes is driving the overall demand across the globe. The Bacillus Calmette-Guerin (BCG) vaccine, given shortly after birth to millions of Indian children to protect them from tuberculosis, may be a “game-changer” in the war against the deadly coronavirus, say US scientists. The magnitude of coronavirus impact could be related to national BCG childhood vaccination policies, the New York Institute of Technology (NYIT) notes yet to be published study while citing examples from Italy and the US.
The global BCG Vaccine Market is segmented on the basis of type, application and geography. Based on type, the global market is bifurcated into immune BCG and therapy BCG. On the basis of application, the global BCG Vaccine Market is segmented into adults and children. Geographically, the market is divided into North America, Europe, Asia-Pacific (APAC), Latin America and Middle East & Africa (MEA). The BCG Vaccine Market has been further segmented into respective countries. The report overall covers 20 countries and regions combined, globally.
There are currently no vaccines or therapies for the novel coronavirus approved by the US Food and Drug Administration. Although hoping the BCG vaccine would prove successful against Covid-19 — as with any of the emerging therapies and vaccines. The key players operating within the global BCG Vaccine Market include Serum Institute of India Ltd., Sanofi, Merck & Co., Inc., InterVax Ltd, China National Pharmaceutical Group Corporation, Green Signal Biopharma Ltd., Statens Serum Institut and Japan BCG Lab among others.
Browse Global BCG Vaccine Industry Report @ https://www.arcognizance.com/report/bcg-vaccine-market-global-industry-analysis-size-share-trends-and-forecast-2015-2025
Table of Content:
Chapter One: Market Introduction
Chapter Two: Executive Summary
Chapter Three: Global BCG Vaccine Market – Key Industry Dynamics
Chapter Four: Global BCG Vaccine Market – Analysis and Revenue Forecast, 2015-2025 – By Type
- 1. Immune BCG
- 2. Therapy BCG
Chapter Five: Global BCG Vaccine Market – Analysis and Revenue Forecast, 2015-2025 – Application
- 1. Adults
- 2. Children
Chapter Six: Global BCG Vaccine Market – Analysis and Revenue Forecast, 2015-2025 – By Region
- 1. North America
- 2. Europe
- 3. Asia-Pacific
- 4. Latin America
- 5. Middle East & Africa
Chapter Seven: North America BCG Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Eight: Europe BCG Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Nine: Asia-Pacific BCG Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Ten: Latin America BCG Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Eleven: Middle East & Africa BCG Vaccine Market – Analysis and Revenue Forecast, 2015-2025
Chapter Twelve: Competitive Analysis
- 1.2.1. Serum Institute of India Ltd.
- 126.96.36.199. Company Details
- 188.8.131.52. Product Portfolio
- 184.108.40.206. Financial Overview
- 220.127.116.11. Main Business Overview
- 18.104.22.168. News
- 1.2.2. Sanofi
- 1.2.3. Merck & Co., Inc.
- 1.2.4. InterVax Ltd
- 1.2.5. China National Pharmaceutical Group Corporation
- 1.2.6. Green Signal Biopharma Ltd.
- 1.2.7. Statens Serum Institut
- 1.2.8. Japan BCG Lab
Chapter Thirteen: Appendix
Chapter Fourteen: Research Conclusions
Make Enquiry of BCG Vaccine Market Report @ https://www.arcognizance.com/enquiry-before-buying/1220661
Buy BCG Vaccine Market Report @ https://www.arcognizance.com/purchase/1220661?license=single
About us: Analytical Research Cognizance (ARC) is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARC’s potential. ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.
Analytical Research Cognizance
+1 (646) 403-4695, +91 90967 44448